Diagnostic antibodies and antigens for pain-related acetaminophen (Paracetamol, Methadone metabolites (EDDP), Methadone (MTD), Fentanyl (FEN), Ketamine (KET), Methamphetamine (MET), Morphine (MOP), Methaqualone (MQL), Opiorphin (OPI), Oxycodone (OXY), Propoxyphene (PPX), Phencyclidine (PCP), Tricyclic antidepressants (TCA), Tetrahydrocannabinol (THC), Tramadol (TRA)) toxicity testing
Acetaminophen is known as paracetamol in many countries outside the US. It is one of the most frequently used oral analgesics and antipyretics. It has an outstanding safety profile when administered in an appropriate dose, but hepatotoxicity can occur after overdose or when misused in at-risk populations. GENEMEDI developed the antigens and antibodies for the diagnosis of potential acetaminophen toxicity based on ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
Paracetamol
Methadone metabolites
Methadone
Fentanyl
Ketamine
Methamphetamine
Morphine
Methaqualone
Opiorphin
Oxycodone
Propoxyphene
Phencyclidine
Tricyclic antidepressants
Tetrahydrocannabinol
Tramadol
acetaminophen (Paracetamol)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-Paracetamol | Human | acetaminophen (Paracetamol) | hepatotoxicity | GMP-SMT-Paracetamol-Ag01: BSA-acetaminophen (Paracetamol); GMP-SMT-Paracetamol-Ag02: OVA-acetaminophen (Paracetamol) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-acetaminophen (Paracetamol)], acetaminophen (Paracetamol) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in Paracetamol level test of Pain (hepatotoxicity) and related syndrome evaluation. | GMP-SMT-Paracetamol-Ab01: Anti-acetaminophen (Paracetamol) mouse monoclonal antibody(mAb) |
Human acetaminophen (Paracetamol) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Paracetamol level test of Pain (hepatotoxicity) and related syndrome evaluation. |
Methadone metabolites (EDDP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-229 | Human | Methadone metabolites (EDDP) | GMP-SMT-229-Ag01: BSA-Methadone metabolites (EDDP) GMP-SMT-229-Ag02: OVA-Methadone metabolites (EDDP) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Methadone metabolites (EDDP), Methadone metabolites (EDDP) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in EDDP level test of Pain and related syndrome evaluation. | GMP-SMT-229-Ab01: Anti-Methadone metabolites (EDDP) mouse monoclonal antibody(mAb) GMP-SMT-229-Ab02: Anti-Methadone metabolites (EDDP) human monoclonal antibody(mAb) | Methadone metabolites (EDDP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Methadone metabolites (EDDP) antibodies in EDDP level test of Pain and related syndrome evaluation. |
Methadone (MTD)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-230 | Human | Methadone (MTD) | GMP-SMT-230-Ag01: BSA-Methadone (MTD) GMP-SMT-230-Ag02: OVA-Methadone (MTD) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Methadone (MTD), Methadone (MTD) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in MTD level test of Pain and related syndrome evaluation. | GMP-SMT-230-Ab01: Anti-Methadone (MTD) mouse monoclonal antibody(mAb) GMP-SMT-230-Ab02: Anti-Methadone (MTD) human monoclonal antibody(mAb) | Methadone (MTD) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Methadone (MTD) antibodies in MTD level test of Pain and related syndrome evaluation. |
Fentanyl (FEN)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-232 | Human | Fentanyl (FEN) | GMP-SMT-232-Ag01: BSA-Fentanyl (FEN) GMP-SMT-232-Ag02: OVA-Fentanyl (FEN) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Fentanyl (FEN), Fentanyl (FEN) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in FEN level test of Pain and related syndrome evaluation. | GMP-SMT-232-Ab01: Anti-Fentanyl (FEN) mouse monoclonal antibody(mAb) GMP-SMT-232-Ab02: Anti-Fentanyl (FEN) human monoclonal antibody(mAb) | Fentanyl (FEN) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Fentanyl (FEN) antibodies in FEN level test of Pain and related syndrome evaluation. |
Ketamine (KET)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-234 | Human | Ketamine (KET) | depression and PTSD | GMP-SMT-234-Ag01: BSA-Ketamine (KET) GMP-SMT-234-Ag02: OVA-Ketamine (KET) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Ketamine (KET), Ketamine (KET) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in KET level test of Pain (depression and PTSD) and related syndrome evaluation. | GMP-SMT-234-Ab01: Anti-Ketamine (KET) mouse monoclonal antibody(mAb) GMP-SMT-234-Ab02: Anti-Ketamine (KET) human monoclonal antibody(mAb) | Ketamine (KET) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Ketamine (KET) antibodies in KET level test of Pain (depression and PTSD) and related syndrome evaluation. |
Methamphetamine (MET)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-236 | Human | Methamphetamine (MET) | GMP-SMT-236-Ag01: BSA-Methamphetamine (MET) GMP-SMT-236-Ag02: OVA-Methamphetamine (MET) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Methamphetamine (MET), Methamphetamine (MET) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in MET level test of Pain and related syndrome evaluation. | GMP-SMT-236-Ab01: Anti-Methamphetamine (MET) mouse monoclonal antibody(mAb) GMP-SMT-236-Ab02: Anti-Methamphetamine (MET) human monoclonal antibody(mAb) | Methamphetamine (MET) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Methamphetamine (MET) antibodies in MET level test of Pain and related syndrome evaluation. |
Morphine (MOP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-237 | Human | Morphine (MOP) | GMP-SMT-237-Ag01: BSA-Morphine (MOP) GMP-SMT-237-Ag02: OVA-Morphine (MOP) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Morphine (MOP), Morphine (MOP) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in MOP level test of Pain and related syndrome evaluation. | GMP-SMT-237-Ab01: Anti-Morphine (MOP) mouse monoclonal antibody(mAb) GMP-SMT-237-Ab02: Anti-Morphine (MOP) human monoclonal antibody(mAb) | Morphine (MOP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Morphine (MOP) antibodies in MOP level test of Pain and related syndrome evaluation. |
Methaqualone (MQL)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-238 | Human | Methaqualone (MQL) | GMP-SMT-238-Ag01: BSA-Methaqualone (MQL) GMP-SMT-238-Ag02: OVA-Methaqualone (MQL) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Methaqualone (MQL), Methaqualone (MQL) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in MQL level test of Pain and related syndrome evaluation. | GMP-SMT-238-Ab01: Anti-Methaqualone (MQL) mouse monoclonal antibody(mAb) GMP-SMT-238-Ab02: Anti-Methaqualone (MQL) human monoclonal antibody(mAb) | Methaqualone (MQL) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Methaqualone (MQL) antibodies in MQL level test of Pain and related syndrome evaluation. |
Opiorphin (OPI)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-239 | Human | Opiorphin (OPI) | GMP-SMT-239-Ag01: BSA-Opiorphin (OPI) GMP-SMT-239-Ag02: OVA-Opiorphin (OPI) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Opiorphin (OPI), Opiorphin (OPI) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in OPI level test of Pain and related syndrome evaluation. | GMP-SMT-239-Ab01: Anti-Opiorphin (OPI) mouse monoclonal antibody(mAb) GMP-SMT-239-Ab02: Anti-Opiorphin (OPI) human monoclonal antibody(mAb) | Opiorphin (OPI) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Opiorphin (OPI) antibodies in OPI level test of Pain and related syndrome evaluation. |
Oxycodone (OXY)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-240 | Human | Oxycodone (OXY) | GMP-SMT-240-Ag01: BSA-Oxycodone (OXY) GMP-SMT-240-Ag02: OVA-Oxycodone (OXY) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Oxycodone (OXY), Oxycodone (OXY) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in OXY level test of Pain and related syndrome evaluation. | GMP-SMT-240-Ab01: Anti-Oxycodone (OXY) mouse monoclonal antibody(mAb) GMP-SMT-240-Ab02: Anti-Oxycodone (OXY) human monoclonal antibody(mAb) | Oxycodone (OXY) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Oxycodone (OXY) antibodies in OXY level test of Pain and related syndrome evaluation. |
Propoxyphene (PPX)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-241 | Human | Propoxyphene (PPX) | GMP-SMT-241-Ag01: BSA-Propoxyphene (PPX) GMP-SMT-241-Ag02: OVA-Propoxyphene (PPX) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Propoxyphene (PPX), Propoxyphene (PPX) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in PPX level test of Pain and related syndrome evaluation. | GMP-SMT-241-Ab01: Anti-Propoxyphene (PPX) mouse monoclonal antibody(mAb) GMP-SMT-241-Ab02: Anti-Propoxyphene (PPX) human monoclonal antibody(mAb) | Propoxyphene (PPX) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Propoxyphene (PPX) antibodies in PPX level test of Pain and related syndrome evaluation. |
Phencyclidine (PCP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-242 | Human | Phencyclidine (PCP) | GMP-SMT-242-Ag01: BSA-Phencyclidine (PCP) GMP-SMT-242-Ag02: OVA-Phencyclidine (PCP) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Phencyclidine (PCP), Phencyclidine (PCP) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in PCP level test of Pain and related syndrome evaluation. | GMP-SMT-242-Ab01: Anti-Phencyclidine (PCP) mouse monoclonal antibody(mAb) GMP-SMT-242-Ab02: Anti-Phencyclidine (PCP) human monoclonal antibody(mAb) | Phencyclidine (PCP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Phencyclidine (PCP) antibodies in PCP level test of Pain and related syndrome evaluation. |
Tricyclic antidepressants (TCA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-243 | Human | Tricyclic antidepressants (TCA) | GMP-SMT-243-Ag01: BSA-Tricyclic antidepressants (TCA) GMP-SMT-243-Ag02: OVA-Tricyclic antidepressants (TCA) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Tricyclic antidepressants (TCA), Tricyclic antidepressants (TCA) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in TCA level test of Neurodegenerative diseases/Pain and related syndrome evaluation. | GMP-SMT-243-Ab01: Anti-Tricyclic antidepressants (TCA) mouse monoclonal antibody(mAb) GMP-SMT-243-Ab02: Anti-Tricyclic antidepressants (TCA) human monoclonal antibody(mAb) | Tricyclic antidepressants (TCA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Tricyclic antidepressants (TCA) antibodies in TCA level test of Neurodegenerative diseases/Pain and related syndrome evaluation. |
Tetrahydrocannabinol (THC)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-244 | Human | Tetrahydrocannabinol (THC) | GMP-SMT-244-Ag01: BSA-Tetrahydrocannabinol (THC) GMP-SMT-244-Ag02: OVA-Tetrahydrocannabinol (THC) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Tetrahydrocannabinol (THC), Tetrahydrocannabinol (THC) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in THC level test of Pain and related syndrome evaluation. | GMP-SMT-244-Ab01: Anti-Tetrahydrocannabinol (THC) mouse monoclonal antibody(mAb) GMP-SMT-244-Ab02: Anti-Tetrahydrocannabinol (THC) human monoclonal antibody(mAb) | Tetrahydrocannabinol (THC) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Tetrahydrocannabinol (THC) antibodies in THC level test of Pain and related syndrome evaluation. |
Tramadol (TRA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-245 | Human | Tramadol (TRA) | GMP-SMT-245-Ag01: BSA-Tramadol (TRA) GMP-SMT-245-Ag02: OVA-Tramadol (TRA) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Tramadol (TRA), Tramadol (TRA) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in TRA level test of Pain and related syndrome evaluation. | GMP-SMT-245-Ab01: Anti-Tramadol (TRA) mouse monoclonal antibody(mAb) GMP-SMT-245-Ab02: Anti-Tramadol (TRA) human monoclonal antibody(mAb) | Tramadol (TRA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Tramadol (TRA) antibodies in TRA level test of Pain and related syndrome evaluation. |